Clinical Trials

581 enrolled

Carcinoma, Non-Small-Cell Lung

NCT07432308 2026-03-06

Liquid biopsy

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01279408 2026-03-04

Observing Patients With Palliative Asymptomatic Centrally Located Advanced Non-small Cell Lung Carcinoma (NSCLC)

46 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03083041 2026-03-03

A Study of SHR-1210 in Combination With Apatinib in Advanced Non-Small Cell Lung Cancer(NSCLC)

210 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT02738398 2026-02-27

FDG PET/CT in Lung Cancer Staging

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03564197 2026-02-27

18F-PD-L1 PET/CT in Nivolumab Treated Patients With NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03724331 2026-02-24

Understanding the Post-Surgical Non-Small Cell Lung Cancer Patient's Symptom Experience

235 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Fatigue, Lung Neoplasms, Motor Activity

NCT03088540 2026-02-23

Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC)

712 enrolled 1 FDA

Carcinoma, Non-Small-Cell Lung

NCT04738487 2026-02-20

Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-003, KEYVIBE-003)

1,264 enrolled 16 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT02523469 2026-02-17

ALT-803 Plus Nivolumab in Patients With Pretreated, Advanced or Metastatic Non-Small Cell Lung Cancer

67 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT06575933 2026-02-11

MK-1084-009

28 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02917993 2026-02-09

An Open-Label Phase 1/2 Study of Itacitinib in Combination With Osimertinib in Subjects With Non-Small Cell Lung Cancer

59 enrolled

Carcinoma, Non-Small-Cell Lung, Inhibition, Psychological, Lung Neoplasms, Neoplasm Metastasis

NCT04384146 2026-02-09

Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

41 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05577702 2026-02-09

Efficacy, Safety, and Pharmacodynamics of Tislelizumab Monotherapy and Multiple Tislelizumab-based Immunotherapy Combinations in Participants With Resectable Non-Small Cell Lung Cancer

121 enrolled 25 charts

Carcinoma, Non-Small-Cell Lung

NCT04809103 2026-02-06

Intratumoral Cisplatin for Resectable NSCLC

6 enrolled 6 charts

Carcinoma, Non-Small-Cell Lung

NCT05812274 2026-02-06

Apricity CARE to Improve ICI Outcomes of Ethnic/Racial Minority NSCLC Patients

30 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05226598 2026-02-05

MK-7684A-007

739 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT04184921 2026-02-03

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

216 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04619797 2026-02-03

SKYSCRAPER-06

Phase 2/3 Completed

542 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05429320 2026-02-02

A Study of Local Ablative Therapy (LAT) in People With Non-Small Cell Lung Cancer (NSCLC)

37 enrolled

Carcinoma, Non-Small-Cell Lung, Neoplasm, Residual

NCT04294810 2026-01-30

SKYSCRAPER-01

620 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06675695 2026-01-30

Emulation of the FLAURA (NCT02296125) Trial Using Specialty Oncology Electronic Health Records Databases

4,864 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03156114 2026-01-26

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

172 enrolled 33 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT07213076 2026-01-21

Australian Retrospective Analysis of EGFRm Advanced & Metastatic NSCLC Patients Treated With 1L or 2L Osimertinib.

350 enrolled

Carcinoma, Non-Small-Cell Lung

NCT03003468 2026-01-20

Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017

35 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung

NCT03285321 2026-01-20

Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer (NSCLC)

105 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT03563716 2026-01-20

A Study of Tiragolumab in Combination With Atezolizumab in Chemotherapy-Naïve Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

135 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT07353489 2026-01-20

easyEndoTM Powered in Thoracic Surgery

61 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07338474 2026-01-14

Mobilization Before and After Video-Assisted Thoracoscopic Surgery Lobectomy/Segmentectomy

51 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00596648 2026-01-13

A Study of XL184 (Cabozantinib) With or Without Erlotinib in Subjects With Non-Small Cell Lung Cancer (NSCLC)

92 enrolled 14 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT04452877 2026-01-13

A Study of Dabrafenib in Combination With Trametinib in Chinese Patients With BRAF V600E Mutant Metastatic NSCLC

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung

NCT05002270 2026-01-13

JAB-21822 Activity in Adult Patients With Advanced Solid Tumors Harboring KRAS G12C Mutation

29 enrolled